Skip to main content

Allison Schwartz's Form 4 filing

Bio-Rad Laboratories, Inc. (BIO) · filed Sep 9, 2026

Accession no.
0001924980-26-000004
Filed
Sep 9, 2026, 6:47 PM ET
Trade date
Sep 4-6, 2026
Filing delay
5 days
Rule 10b5-1 plan
Not checked

This filing lists 4 non-derivative transactions and 3 derivative transactions. It was filed 5 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Allison SchwartzCIK 0001924980Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 5, 2026Bio-Rad A Common StockMOption exerciseAcquired+228$0.00$01,758Direct
Sep 5, 2026Bio-Rad A Common StockFTax withholdingDisposed−82$386.11−$31,661.021,676Direct
Sep 6, 2026Bio-Rad A Common StockMOption exerciseAcquired+92$0.00$01,768Direct
Sep 6, 2026Bio-Rad A Common StockFTax withholdingDisposed−34$386.11−$13,127.741,734Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Sep 4, 2026Bio-Rad A Common StockAGrant or awardAcquired+719$0.00$0719Direct
Sep 5, 2026Bio-Rad A Common StockMOption exerciseDisposed−228$0.00$0686Direct
Sep 6, 2026Bio-Rad A Common StockMOption exerciseDisposed−92$0.00$0185Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)